News Powered By:
- a collaborative partner.
CenterWatch News Online Headlines : December 5, 2013 4:49 am : Centerwatch
The Fred Hutchinson Cancer Research Center (Fred Hutch) and Memorial Sloan-Kettering Cancer Center (MSKCC), along with pediatric partner Seattle Children’s Research Institute, have joined forces to launch Juno Therapeutics, a new biotechnology company focused on bringing forward novel immunotherapies for cancer.
CenterWatch News Online Headlines : December 5, 2013 4:36 am : Centerwatch
Bruin Biometrics (BBI) has announced results from two IRB-approved clinical trials conducted with the SEM Scanner, a Class IIA medical device that is intended to detect localized tissue edema and pressure induced tissue damage which may lead to the formation of pressure ulcers.
CenterWatch News Online Headlines : December 5, 2013 3:56 am : Centerwatch
Lexicon Pharmaceuticals has announced top-line results from an initial phase II study exploring the use of LX1033 in diarrhea-predominant irritable bowel syndrome (IBS-d). LX1033 is an investigational drug that inhibits serotonin synthesis in the gastrointestinal tract. Serotonin is a neurotransmitter that has been shown to play a role in the symptoms of irritable bowel syndrome.
CenterWatch News Online Headlines : December 5, 2013 2:04 am : Centerwatch
Aptuit has appointed Jonathan Goldman, M.D., as CEO. Goldman will focus on the growth of Aptuit as a provider of outsourced services in the early development space by establishing new partnerships with clients and pursuing strategic acquisitions. He joins the company after success at Icon Clinical Research, a global CRO specializing in the provision of clinical and other solutions that support phase I-IV clinical studies.
CenterWatch News Online Headlines : December 4, 2013 8:33 am : Centerwatch
Researchers have used radioimmunotherapy (RIT) to destroy remaining human immunodeficiency virus (HIV)-infected cells in the blood samples of patients treated with antiretroviral therapy, offering the promise of a strategy for curing HIV infection. Results of the study were presented at the annual meeting of the Radiological Society of North America (RSNA).